Daiwa Securities Upgrades Merck (MRK) to Outperform (2)

Daiwa Securities analyst Narumi Nakagiri upgraded Merck (NYSE: MRK) from Neutral (3) to Outperform (2) with a price target of $143.00 (from $120.00).

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $130.42 yesterday.

You May Also Be Interested In

• JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
• Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
• Polaris Industries (PII) PT Lowered to $61 at UBS, Neutral Rating Maintained